Investigation of the pharmacological treatment patterns of Chinese patients with major depressive disorder under real-world settings using multi-channel sequence analysis

Bibliographic Data

ID15529936
AuthorsTina Wu (0000-0003-0147-8420), Tao Wu (0000-0002-0133-6783), Sijia Dong, Lu Yang (0000-0002-2623-6789, Shanghai Jiao Tong University), Hong Qiu (0000-0002-4960-8661, Shanghai Mental Health Center), D Mellor (0000-0001-5007-5906, Deakin University), Jun Chen (0000-0002-3850-4875, Center for Excellence in Brain Science and Intelligence Technology, corresponding author), Yifeng Xu (0000-0002-0403-1141, Shanghai Mental Health Center, corresponding author)
Year2023
Volume14
Pages1089504-1089504
Publication date2023-04-06
Open AccessYes
TypeARTICLE
VenueFrontiers in Psychiatry (JOURNAL)
Journal identifiersISSN: 1664-0640 • E-ISSN: 1664-0640
PublisherFrontiers Media (PUBLISHER • CH)
DOI10.3389/fpsyt.2023.1089504
PMID37091706
OpenAlexW4362671967
LanguageEN
References cited30

Treatment patterns reflecting real-world pharmacological treatment practices of MDD in China were revealed using MCSA. The observed discrepancies between real-world practice and treatment guidelines provided additional insights in improving the clinical management of MDD

Antidepressant · Major depressive disorder · Medical prescription · Mood · Polypharmacy · Psychiatry · Medicine · Mental Health Research Topics · Schizophrenia research and treatment · Treatment of Major Depression · Internal Medicine · Pharmacology

Tools

Open DOIOpen Access